| Tag | Content |
|---|
EnhancerAtlas ID | HS034-12233 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr17:19234380-19235160 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFAT5 | MA0606.1 | chr17:19234815-19234825 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr17:19234815-19234825 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr17:19234815-19234825 | AATGGAAAAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_04799 | chr17:19234112-19236605 | Brain_Cingulate_Gyrus | | SE_05794 | chr17:19231987-19234467 | Brain_Hippocampus_Middle | | SE_05794 | chr17:19234516-19238258 | Brain_Hippocampus_Middle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I019329 | chr17 | 19233312 | 19236361 |
|
Enhancer Sequence | TTGCCTCAAC TTTTGTGGAT TAACAGATTG AAAACATCTT CTCATGACTT TAAAACTTGT 60
TAAAAAATAC TTTGTTGCTA TATAATCTCT CTTTATATGG CTCAGCAACA ATTCAATAAT 120
TTGGGGGAGG ACATTTTAGG TTGATTTCAG GTTTTGCTAC TGTAAATGAT GCTGTTGTGA 180
AACTCTTTGT GCTTATAACC TTGTTCACAT TTTACATTAT TTGCTTAGAC CAGATTCCTA 240
GAAATGGGGT TACTAAGTGA GAGAATGACT GTTGTTAAGA ATTCCTGTAC CGTGAAGCAT 300
CCCGTCGTGG CAATCACATT CCTACCGGCC TGGCTCAGCA CAGCCTGTGT TGCCTCTATG 360
GGCTGAATTT TAAAAGACAC AATTTGCTTT CTTTTTACTA TCAAGAAGTT CATGTTTATT 420
GTGGAAAATT TAGTAAATGG AAAATGTAAG AAAAAAAAAA AAAAGTAAAT TGCCCATGCC 480
TAGCTTCCAA CCCAAAATGA CATCTTGGTA TTCTGGAGGA ATGAGCTATA CACACTCTTT 540
TATAACCTGC TTTAGTATTT TGATAAAGCT TTCTTTGCTT ATCATTAGGT ATTCTTCTGT 600
TCCTGCATGC TGGTGTTTCG TTATGTGGAC ACTTGATTTA TCTAACCCAG CCCATGACTG 660
GCTGTGTGTC GTCACGTGGC GCTGTCAGGC AGGCATGTCC CCAGGAGGCC ATGTTTTGTG 720
TTAAGTACAC AGTCTTAGGC TCTCCCTGCC ACACTCACCC TGCCATATGT GTCCTTGTCT 780
|
